glp-1 atrial fibrillation Association of glucagon-like peptide-1 receptor agonists with fibrillation, cardiac arrest, and ventricular fibrillation: Casual evidence from a drug target Mendelian randomization | Diabetology & Metabolic Syndrome Abstract 4368472: Glucagon-Like Peptide 1

Sources Review of GLP-1 Medicines for Obesity and Symptoms in Menopause Fat Mass Changes During Menopause: a Metaanalysis The 2023 Nonhormone Therapy Position Statement of The North American Menopause Society Vasomotor Symptoms Across the Menopause Transition: Differences Among Women The Impact of the Menopausal Transition on Body Composition and Abdominal Fat Redistribution Wilding JPH et al

Santiago JA, Karthikeyan M, Lackey M, Villavicencio D, Potashkin JA

If you've spent any time researching weight loss medications, you've probably noticed that Wegovy, Zepbound, Mounjar

At CES 2025 in January, the Consumer Technology Association (CTA) ranked Longevity among its five tech trends for 2025 and GLP-1s fall into that category alongside digital health technologies

GLP-3 Program: Maximum Support First Month: $249 (regularly $349), then $349/month ongoing

Individual results may vary.